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Accepted 14 June 2012AbstractObjective: To evaluate the normal range of the fetal nasal bone length (NBL) in Taiwanese women using three-dimensional (3D) ultrasound, and
compare the NBL of normal fetuses with Down syndrome to determine its significance in screening for trisomy 21.
Materials and Methods: A total of 102 consecutive fetuses and another 7 fetuses with trisomy 21, determined by karyotyping at 15e22 weeks’
gestation, were evaluated with 3D ultrasound before amniocentesis at Changhua Christian Hospital between November 2003 and April 2004.
Results: The normal range for NBL in the second trimester in the Taiwanese population was investigated, and a linear relationship with
gestational age was noted. The NBL increased with advancing gestational age (NBL in cm¼ 0.0264 gestational age in weeks e0.042
(R2¼ 0.2416). The median of the biparietal diameter/nasal bone length ratio had a stable value which tended to change minimally between 15
and 22 weeks of gestation. Chromosomally normal fetuses had statistically longer nasal bones than fetuses with Down syndrome ( p¼ 0.014).
Conclusion: We present a reference range for 3D ultrasound measurement of the fetal NBL. A short nasal bone at 15 to 22 weeks is associated
with a high risk of trisomy 21.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Facial abnormalities, including a flat facial profile and
a small nose, are often noted in newborns with Down
syndrome. The association between the sonographic absence
or hypoplasia of the fetal nasal bone and Down syndrome in
the first and mid-second trimesters has been reported [1e6].
Sonographic findings of fetal nasal bone hypoplasia in the
second trimester have a sensitivity of 77.7% with a false-
positive rate of 0.9% in screening for trisomy 21 [7]. Exami-
nation of the fetal nose and its measurement serves as an
objective method of prenatal detection of Down syndrome.
Normal values for fetal nasal bone measurements have been
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http://dx.doi.org/10.1016/j.tjog.2012.07.006populations [4,8,9]. Cicero et al [4] reported that within the
chromosomally normal group in the second trimester, hypo-
plastic nasal bones were found in 0.5% of Caucasians and
8.8% of Afro-Caribbean people. Chen et al [9] and Hung et al
[10] analyzed the fetal nasal bone length (NBL) of normal
fetuses in the second trimester in a Chinese population in
a pilot study with two-dimensional (2D) ultrasonography.
They concluded that the fetal NBL in the Chinese population
appeared shorter than that in white and black people.
We conducted a preliminary study with 3D ultrasound to
compare the NBL and biparietal diameter (BPD)/NBL ratio
between fetuses of Taiwanese women, and compared this
result with fetuses with trisomy 21.
Materials and methods
Between November 2003 and April 2004, a total of 102
Taiwanese gravidas undergoing prenatal ultrasound examina-
tion at Changhua Christian Hospital at 15 to 22 weeks ofcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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a high risk of aneuploidy. Patients who met one or more of the
following criteria were included: maternal age >35 years, risk
of trisomy 21 >1:270 based on combined maternal serum test
results (including b-human chorionic gonadotropin, a-feto-
protein, unconjugated estriol, and inhibin-A), prior pregnancy
carrying a fetus with trisomy 21, or an enlarged nuchal
translucency >3 mm. The exclusion criteria were fetal death,
maternal complications, and fetal anomalies diagnosed by
ultrasound. Seven fetuses with trisomy 21 confirmed by
karyotype also received fetal nasal bone measurements as
described below.
Examination of the fetal nasal bone and measurement of
the fetal NBL were performed by two skilled ultrasonogra-
phers (C.T.C. H.; J.L. Wu). Using an abdominal probe (Vol-
usion 730 Expert; General Electric, Milwaukee, WI, USA) an,
following the method described by Rembouskos et al [11], 3D
volume datasets were acquired by longitudinal screening of
the fetal face using notarized curved array transducers (2e5
and 4e8 MHz). Three-dimensional reconstruction of the nasal
bones in the anterioreposterior and profile projection views
was performed with a maximum intensity projection algo-
rithm. The maximum intensity mode is a rendering algorithm
applied to 3D demonstrations of bone structure. All fetuses
were successfully recorded three times. A midline sagittal
view of the facial profile was chosen during post-scan analysis.
Biometry and measurement of the NBL were obtained
(Fig. 1). A permanent record of the image was retained on
a hard disk and VCD-ROM.Statistical analysisStatistical analysis was performed with SPSS for Windows
I O software (SPSS, Inc., Chicago, IL, USA). A p value <0.05
was considered statistically significant.Fig. 1. The fetal nasal bone is measured by three-dimensional ultrasound using both
from the ventral direction. The bottom-right panel reveals both nasal bones.Results
A total of 102 fetuses with normal karyotype were enrolled
in the present study. The median gestational age was 17.9
weeks. All fetuses were considered suitable for analysis.
Examination of the facial profile was successful in all cases.
Table 1 shows the median, maximal, and minimal data of
the NBL at different gestational ages.
Regression analysis demonstrated a significant positive
correlation between the fetal NBL and gestational age
( p< 0.05), as follows: NBL (cm)¼ 0.0264 gestational age
in weeks e0.042 (R2¼ 0.2416). The resulting reference
ranges are graphically illustrated in Fig. 2. The relation
between NBL and BPD within 15e22 weeks of gestation is
also shown in Fig. 2 (NBL cm¼ 0.122 BPD e 0.609;
R2¼ 0.3829, R< 0.001). Fetuses with trisomy 21 had
a shorter NBL than euploid fetuses, despite having a similar
BPD and gestational age, as shown in Table 2 ( p¼ 0.014).
In our results, the expected values of the BPD/NBL ratio
were significantly different between the eupoloid fetuses and
the trisomy 21 fetuses from 15 to 22 weeks. In the eupoloid
fetuses, the mean of the BPD/NBL ratio was 9.573, the SD
was 1.625, and the regression equation was BPD/
NBL¼ 11.421 e 0.0999 gestational age in weeks; in the
trisomy 21 group, the mean of the BPD/NBL ratio was 14.261,
the SD was 3.964, and the regression equation reported BPD/
NBL¼ 47.841 e 1.7467 gestational age in weeks (Table 2,
Fig. 3).
Table 2 also shows a comparison of the BPD/NBL ratio in
the two groups (Down syndrome and normal fetus group). The
p value was <0.001. The BPD/NBL ratio in fetuses with
Down syndrome was statistically higher than that in fetuses
that were chromosomally normal.
Table 3 shows the results of multiple linear regression of
the BPD/NBL ratio; if the predictor was gestational age (GAthe surface and max modes. A rendering box over a normal surface is viewed
Table 1
Length of the nasal bone (cm) in the mid-second trimester in Taiwanese
fetuses.
Nasal bone
GA week N Mean SD Median Min Max
16 14 0.399 0.069 0.399 0.289 0.542
17 37 0.425 0.087 0.441 0.258 0.572
18 14 0.432 0.058 0.451 0.330 0.505
19 16 0.448 0.072 0.473 0.309 0.553
20 10 0.539 0.062 0.537 0.446 0.678
21 7 0.533 0.072 0.525 0.448 0.684
22 4 0.513 0.109 0.506 0.413 0.626
GA¼ gestational age.
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predictor was groups (Down syndrome or normal fetuses
group), the p value was <0.001. We proposed that the BPD/
NBL ratio of the fetuses in the Taiwanese population from 15
to 22 weeks gestational age had a stable value and changed
minimally, and is not related to gestational age but related to
Down syndrome fetuses.
Discussion
The aim of this study was to establish the reference range
of the NBL with 3D ultrasound throughout the gestation
period of 15 to 22 weeks based on chromosomally normal
Taiwanese fetuses, as 3D ultrasound is presumed to be helpful
in identifying the exact sagittal plane for an accurate NBL
measurement.
The nasal bones develop from paired independent ossifi-
cation tissues located in a membrane within the cone-septal
cartilage of the nasal capsule. Several studies have proposed
that delayed maturation of the nasal bones may be a possible
explanation for the increasing prevalence of absent or hypo-
plastic nasal bones in fetuses with Down syndrome [12,13].
Some histological sections or radiologic studies have revealed
asymmetric distribution or unilateral absence of nasal bone
tissue in fetuses with Down syndrome.
Hypoplastic nasal bones are more easily identified and
missed less often on 3D-rendered anterioreposteriorNBLN = 0.122BPD - 0.0609
R2 = 0.3829
NBLD = 0.1756BPD - 0.4572
R2 = 0.5879
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Fig. 2. Distribution of nasal bone length (mm) in the study population.
A¼ normal karyotype; B¼Down syndrome; BPD¼ biparietal diameter;
NBL¼ nasal bone length.projection views [14,15]. Previous studies reported the
absence of the nasal bone as the single most sensitive and
specific second trimester marker for trisomy 21 in all pop-
ulations. On 2D or 3D prenatal ultrasonography, absent or
hypoplastic nasal bones occur in 40e70% of first and second
trimester fetuses with Down syndrome, but also in approxi-
mately 1% of the normal population [1,5,14]. In the study
conducted by Benoit and Chaoui [14], the detection rate was
45% in the 3D-rendered mode. They suggested that maximal
mode rendering in 3D and 4D should be used for suspicious
findings of absence or hypoplasia of the nasal bone.
Goncalves et al [15] reported that 9 of 10 fetuses with
absent nasal bones had Down syndrome, 42.3% (11 of 26) of
fetuses with Down syndrome showed hypoplastic nasal bones,
and a unilateral bone was found in only one case. Furthermore,
hypoplastic nasal bone was also observed in 22.2% (6 of 27)
cases of the fetuses without abnormalities in their study group,
including 27 normal fetuses and 26 Down syndrome fetuses
confirmed by karyotype. The risk of Down syndrome in
fetuses with hypoplastic nasal bones is lower than in those
with complete absence of the nasal bones. In their conclusions,
they noted that the hypoplastic nasal bone might be not
identified on 2D ultrasound.
The measurement of the nasal bone by 2D ultrasound was
significantly influenced by fetal position and the angle
between the ultrasound beam and the axis of the nasal bone.
Through 3D ultrasound, we can improve the accuracy of nasal
bone measurements. We can also measure hypoplastic nasal
bones by 3D ultrasound, although the efficiency seems lacking
[14].
Increasing NBL with gestation and with BPD was again
demonstrated in our study population. In the study by Hung
et al [10], the reference value at a gestational age of 18 weeks
was 5.29 0.05 mm. In our data, the value reported was
4.32 0.058 mm. Jung et al [16] proposed an NBL value of
4.0 0.66 mm at 18 weeks of gestation in a South Korean
population. Our data have established reference ranges of the
NBL at different gestational ages in normal singleton Taiwa-
nese fetuses with 3D ultrasound measurement of the NBL.
Some researchers have attempted to use the BPD/NBL ratio
for further scanning purposes, because the size of the nasal
bone in unaffected pregnancies is gestational age-dependent
[3]. In Bromley et al’s study [3], the BPD/NBL ratio in
euploid fetuses was 8.1 1.4 compared with 11.3 2.0 in
fetuses with trisomy 21. In another study conducted on
a healthy Japanese population, the BPD/NBL ratio was
9.01 1.20 [17]. In our study, the ratio was 9.573 1.625. We
speculate that the ratio is stable and changed minimally
unrelated to the gestational age of fetuses in Taiwanese women
at 15 to 22 weeks of gestation, as shown in Table 3. This result
was also noted in a previous study. In one study, the optimal
cutoff of the BPD/NBL ratio for optimizing sensitivity and
specificity was 10, which allowed identification of 81% of
fetuses with trisomy 21 with a false-positive rate of 11% [3].
Tran et al [18] reported an 81% detection rate, but a false-
positive rate of 44% under the same criteria. Odibo et al
[19] reported that the use of BPD/NBL > 11 provided
Table 2
Comparison of NBL and BPD/NBL ratio in fetuses with a normal karyotype and those with Down syndrome.
Group
p
Normal (n¼ 102) Down syndrome (n¼ 7)
Mean SD Median Min Max Mean SD Median Min Max
GA week 18.508 1.622 17.929 16.143 22.857 19.229 1.340 18.600 18.000 21.400 0.108
BPD (cm) 4.172 0.441 4.110 3.360 5.320 4.564 0.520 4.460 3.760 5.180 0.053
Nasal bone length (cm) 0.448 0.087 0.451 0.258 0.684 0.344 0.119 0.310 0.200 0.560 0.014
BPD/NBL 9.573 1.625 9.192 7.200 14.865 14.261 3.964 14.387 9.250 22.150 <0.001
p value by ManneWhitney U-test. BPD¼ biparietal diameter; GA¼ gestational age; NBL¼ nasal bone length.
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a specificity of 85% (95% confidence interval, 84e86%) for
detecting Down syndrome. Our BPD/NBL ratio in normal
Taiwanese fetuses seems slightly higher. One possible reason
is the shorter NBL in the Taiwan population. Odibo et al and
Tran et al did not adjust for race in their studies of NBL [3,19].
Maymon et al [20] combined prenasal thickness with NBL
for detecting Down syndrome, and their results achieved
a 70% detection rate with a 5% false-positive rate, in which
data were expressed as multiples of the normal gestation-
specific median (MoM). Gianferrari et al [21] proposed
using NBL < 0.8 MoM as a cutoff for detecting Down
syndrome fetuses; the sensitivity achieved 95.2%, and the
false-positive rate was 7.4%. If the cutoff was lowered to 0.75
MoM, it resulted in a sensitivity of 85.7% and a 2.9% false-
positive rate. They also emphasized that using cutoffs only
derived from a Caucasian population to calculate MoM for theBPD/NBLN = -0.0999GA week + 11.421
R2 = 0.0099
BPD/NBLD = -1.7467GA week + 47.841
R2 = 0.3485
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Fig. 3. BPD/NBL ratio versus gestational age (GA) in the study population.
A¼ normal karyotype; B¼Down syndrome; BPD¼ biparietal diameter;
NBL¼ nasal bone length.
Table 3
Multiple linear regression results of BPD/NBL.
Predictors b SE Std b 95% CI for b p R2
(Constant) 12.236 1.970 8.330 to 16.142 <0.001 0.297
GA Week 0.147 0.109 0.111 0.362 to 0.068 0.178
Group
(Down vs.
Normal)
4.803 0.720 0.547 3.376 to 6.230 <0.001
BPD¼ biparietal diameter; GA¼ gestational age; NBL¼ nasal bone length.entire population might result in increased false-positive rates.
The multiplicative correction factor for the Asian race was
0.948 for NBL. They also concluded that detecting fetuses
with Down’s syndrome using the BPD/NBL ratio is a useful
method. In their study population, the correction factor was
listed as 1.0500 for Asian women [ 21]. However, the study
included fewer than 100 Asian women. In another study by
Odibo et al [22], in which 218 Asian women were enrolled,
a factor of 0.96 was used for correcting normal medians of
nasal bones [22]. These correction factors were calculated for
the authors’ study population by comparing the median values
of the Caucasian population to other races. It seems to need
more data on Asian pregnant women population for calcu-
lating a more specific ethnicity-adjusted correction factor.
Our data echoed the results of ethnicity-adjusted BPD/NBL
ratios reported in other studies [8,11,21]. Shorter nasal bones
were noted in our study compared with the study by Hung et al
[9]. This may be attributed to the estimated accuracy of using
2D or 3D ultrasound or the limited number of fetuses. We
agree with the conclusions in other studies that shortened nasal
bones are a useful ultrasound marker for detecting Down
syndrome in second trimester fetuses. So far, the most sensi-
tive and effective method for screening fetuses with Down
syndrome is undeniably a combination test of maternal age,
fetal nuchal translucency, and maternal serum free b-human
chorionic gonadotropin and pregnancy-associated plasma
protein-A at 11 to 14 weeks of gestation. Measurement of
NBL in the second trimester might be an alternative to serum-
based second trimester Down syndrome screening in pregnant
women who were not screened in the first trimester of
pregnancy.
Although we set the reference range of nasal-bone length of
the normal Taiwanese population in the early second trimester
using 3D ultrasound, a large, fully prospective study is
required to confirm our observations.References
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